It was a medical enigma: Why do many black patients respond differently to a class of heart drugs called beta blockers? Researchers now say a genetic variant allows 40 percent of black patients to produce their own version of the drugs. Dr. Stephen Liggett tells The Takeaway about his study and the potential impacts on health care.
Guest: Dr. Stephen Liggett, director of Cardiopulmonary Genomics at University of Maryland Medical Center.
At The World, we believe strongly that human-centered journalism is at the heart of an informed public and a strong democracy. We see democracy and journalism as two sides of the same coin. If you care about one, it is imperative to care about the other.
Every day, our nonprofit newsroom seeks to inform and empower listeners and hold the powerful accountable. Neither would be possible without the support of listeners like you. If you believe in our work, will you give today? We need your help now more than ever!